Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NRXS stock hub

NeurAxis, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NRXSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

94.3M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

NRXS

In the news

Latest news · NRXS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-285.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-141.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NRXS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001933567
Company name	NeurAxis, Inc.
Country	United States
Country code	US
Cusip	64134X201
Employees	24
Employees Change	3%
Employees Change Percent	14.29
Enterprise value	$89.8M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-08-09
Isin	US64134X2018
Last refreshed	2026-05-10
Market cap	$94.3M
Market cap category	Micro-Cap
Price	$8.2
Price currency	USD
Rev Per Employee	148,720.08x
Sector	Healthcare
Sic	3845
Symbol	NRXS
Website	https://neuraxis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.13%
EV Sales Forward	9.12x
EV/Sales	25.16x
FCF yield	-6.85%
P/B ratio	25.73x
P/S ratio	26.43x
PS Forward	9.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-201.7%
EBITDA Margin	-200.04%
Gross margin	84.23%
Gross Profit	$3M
Gross Profit Growth	29.37%
Gross Profit Growth Q	25.97%
Gross Profit Growth3 Y	7.98%
Net Income	$-8.6M
Net Income Growth Years	0%
Pretax Margin	-218.55%
Profit Margin	-218.55%
Profit Per Employee	$-358,965
ROA	-80.63
Roa5y	-192.3
ROCE	-199.3
ROE	-285.4
ROIC	-141.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	290.84%
EPS Growth Quarters	3
EPS Growth Years	2
Revenue Growth	32.89x
Revenue Growth Q	27.19x
Revenue Growth Quarters	6x
Revenue Growth Years	2x
Revenue Growth3 Y	9.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.64
Assets	$6.4M
Cash	$5M
Current Assets	$5.7M
Current Liabilities	$2.8M
Debt	$426,610
Debt Equity	$0.13
Equity	$3.4M
Interest Coverage	-97.33
Liabilities	$3M
Long Term Assets	$670,846
Long Term Liabilities	$212,565
Net Cash	$4.5M
Net Cash By Market Cap	$4.81
Net Cash Growth	40.79%
Net Debt Equity	$-1.34
Tangible Book Value	$3.1M
Tangible Book Value Per Share	$0.29
WACC	12.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.05
Inventory Turnover	3.73
Net Working Capital	$-1.8M
Quick ratio	1.85
Working Capital	$2.9M
Working Capital Turnover	$1.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	290.48%
200-day SMA	4.26
50-day SMA	7.16
50-day SMA vs 200-day SMA	50over200
All Time High	9.33
All Time High Change	-12.11%
All Time High Date	2026-05-05
All Time Low	1.33
All Time Low Change	516.54%
All Time Low Date	2025-04-16
ATR	0.65
Beta	1.48
Beta1y	-0.06
Beta2y	0.73
Ch YTD	80.62
High	8.9
High52	9.33
High52 Date	2026-05-05
High52ch	-12.11%
Low	8.19
Low52	2
Low52 Date	2025-05-09
Low52ch	310%
Ma50ch	14.53%
Premarket Change Percent	1.82
Premarket Price	$8.96
Premarket Volume	373
Price vs 200-day SMA	92.49%
RSI	57.54
RSI Monthly	75.33
RSI Weekly	75.53
Sharpe ratio	1.67x
Sortino ratio	3.74
Total Return	-31.28%
Tr YTD	80.62
Tr1m	11.72%
Tr1w	1.49%
Tr3m	88.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Count Top	1
Analyst Price Target Top	$13
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.19
Earnings Revenue Estimate	1,450,000x
Earnings Revenue Estimate Growth	61.89x
Operating Income	$-7.2M
Operating margin	-201.7
Price target	$13
Price Target Change	$58.54
Price Target Change Top	$58.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,880,431%
Float Percent	68.49%
Net Borrowing	-281,751
Shares Insiders	28.13%
Shares Institutions	14.25%
Shares Out	11,505,421
Shares Qo Q	7.58%
Shares Yo Y	31.28%
Short Float	3.34%
Short Ratio	1.29
Short Shares	2.29

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.1M
Average Volume	201,130.85x
Bv Per Share	0.32
CAPEX	$-31,150
Ch1m	11.72
Ch1w	1.49
Ch1y	290.5
Ch3m	88.51
Ch6m	222.8
Change	-6.82%
Change From Open	-6.82
Close	8.8
Days Gap	0
Depreciation Amortization	59,501
Dollar Volume	1,286,268.4
Earnings Date	2026-05-12
Earnings Time	bmo
EBIT	$-7.2M
EBITDA	$-7.1M
EPS	$-0.95
F Score	2
FCF	$-6.5M
FCF EV Yield	-7.2x
FCF Per Share	$-0.56
Financing CF	7,832,195
Fiscal Year End	December
Founded	2,011
Investing CF	-131,150
Ipr	36.67
Iprfo	30.16
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	4.82
Ma150ch	70.02%
Ma20	7.72
Ma20ch	6.25%
Net CF	1,268,202
Next Earnings Date	2026-05-12
Open	8.8
Optionable	No
Position In Range	1.41
Ppne	337,129
Pre Close	8.8
Price Date	2026-05-08
Ptbv Ratio	30.23
Relative Volume	0.78x
Revenue	3,569,282x
SBC By Revenue	16.72x
Share Based Comp	596,852
Tr6m	222.84%
Us State	Indiana
Volume	156,862
Z Score	-12.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NRXS pay a dividend?

Capital-return profile for this ticker.

Performance

NRXS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NRXS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.3%

Float: +68.5% of shares outstanding

Insider ownership

+28.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NRXS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.5

Neutral momentum band

Price vs 200-day MA

+92.5%

50/200-day relationship not available

Beta (5Y)

1.48

More volatile than the market

Sharpe ratio

1.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NRXS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NRXS stock rating?

NeurAxis, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NRXS analysis?

The full report lives at /stocks/NRXS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NRXS?

The latest report frames NRXS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NRXS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.